NSPH News Alert Nanosphere Inc (NSPH) 0.37 12/17/2014 04:11:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nanosphere Inc (NSPH) 0.37 $NSPH

Stock to Watch: Nanosphere Up 16.4% (NSPH)
Comtex SmarTrend(R) - Thu Dec 11, 11:35AM CST
Nanosphere (NASDAQ:NSPH) is one of today's best performing penny stocks, up 16.4% to $0.41 on 1.2x average daily volume. Nanosphere has traded 2.6 million shares thus far today, vs. average volume of 2.2 million shares per day. The stock has outperformed the Dow (16.4% to the Dow's 1.2%) and outperformed the S&P 500 (16.4% to the S&P's 1.3%) during today's trading.
NSPH: 0.37 (+0.02)

Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma
PR Newswire - Thu Dec 04, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: OPKO Health Inc. (NYSE: OPK), IsoRay Inc. (NYSE MKT: ISR), Nanosphere Inc. (NASDAQ: NSPH), Amicus Therapeutics Inc. (NASDAQ: FOLD), and Isis Pharmaceuticals Inc. (NASDAQ: ISIS). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Wednesday, December 03, 2014, the NASDAQ Composite ended at 4,774.47, up 0.39%, the Dow Jones Industrial Average advanced 0.18%, to finish the day at 17,912.62, and the S&P 500 closed at 2,074.33, up 0.38%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 812.13, up 0.15%, with the index also advancing 9.64% in the previous three months. Register for your complimentary reports on these five stocks at:
ISIS: 54.94 (-1.99), OPK: 8.70 (-0.16), ISR: 1.50 (-0.02), FOLD: 7.73 (-0.15), NSPH: 0.37 (+0.02)

SEC suspends trading in certain Ebola-related stocks
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 10:03AM CST

BCRX: 10.23 (+0.14), VSR: 3.00 (-0.04), TKMR: 13.12 (-0.19), NNVC: 2.61 (+0.03), INO: 8.34 (+0.08), CMRX: 34.77 (-0.27), APT: 2.52 (-0.07), HEB: 0.23 (-0.01), SRPT: 12.60 (-0.40), SMED: 4.33 (+0.08), PLX: 2.02 (-0.12), NLNK: 33.10 (-0.36), LAKE: 9.19 (-0.46), NSPH: 0.37 (+0.02)

Aethlon Medical up on successful Ebola treatment
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 11:06AM CST

BCRX: 10.23 (+0.14), VSR: 3.00 (-0.04), TKMR: 13.12 (-0.19), NNVC: 2.61 (+0.03), INO: 8.34 (+0.08), CMRX: 34.77 (-0.27), APT: 2.52 (-0.07), HEB: 0.23 (-0.01), SRPT: 12.60 (-0.40), SMED: 4.33 (+0.08), NLNK: 33.10 (-0.36), PLX: 2.02 (-0.12), LAKE: 9.19 (-0.46), NSPH: 0.37 (+0.02)

OTC Daily Alert Stock Watch - Nanosphere, Inc.. (NASDAQ: NSPH)
WorldStockWire - Mon Nov 10, 12:45PM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
NSPH: 0.37 (+0.02)

Nanosphere's (NSPH) CEO Michael McGarrity on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 6:15PM CST

NSPH: 0.37 (+0.02)

Nanosphere beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:30PM CST

NSPH: 0.37 (+0.02)

Nanosphere Announces Third Quarter Financial and Operating Results
GlobeNewswire - Wed Nov 05, 3:01PM CST
Corporate Highlights and Business Guidance:
NSPH: 0.37 (+0.02)

Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma
PR Newswire - Fri Oct 31, 7:40AM CDT
Investor-Edge has initiated coverage on the following equities: Nanosphere Inc. (NASDAQ: NSPH), Isis Pharmaceuticals Inc. (NASDAQ: ISIS), Halozyme Therapeutics Inc. (NASDAQ: HALO), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), and Synta Pharmaceuticals Corporation (NASDAQ: SNTA). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, October 30, 2014, the NASDAQ Composite ended at 4,566.14, up 0.37%, the Dow Jones Industrial Average advanced 1.30%, to finish the day at 17,195.42, and the S&P 500 closed at 1,994.65, up 0.62%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 774.91, up 1.81%, with the index also advancing 7.78% in the previous three months. Register for your complimentary reports on these five stocks at:
SNTA: 2.66 (+0.02), ACAD: 30.02 (-0.32), HALO: 7.64 (-0.03), ISIS: 54.94 (-1.99), NSPH: 0.37 (+0.02)

Nanosphere reports November 5
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 3:07PM CDT

NSPH: 0.37 (+0.02)

Nanosphere to Release Third Quarter Results and Host Investor Conference Call on Wednesday, November 5
GlobeNewswire - Tue Oct 28, 3:01PM CDT
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results for the third quarter of 2014 on Wednesday, November 5, 2014. The company will also hold a live investor conference call and webcast at 5:00pm Eastern/2:00pm Pacific.
NSPH: 0.37 (+0.02)

CDC issues new guidelines over Ebola
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 3:10AM CDT

BCRX: 10.23 (+0.14), VSR: 3.00 (-0.04), TKMR: 13.12 (-0.19), NNVC: 2.61 (+0.03), INO: 8.34 (+0.08), CMRX: 34.77 (-0.27), APT: 2.52 (-0.07), HEB: 0.23 (-0.01), SRPT: 12.60 (-0.40), SMED: 4.33 (+0.08), NLNK: 33.10 (-0.36), PLX: 2.02 (-0.12), LAKE: 9.19 (-0.46), NSPH: 0.37 (+0.02)

Nanosphere, Inc. Announces the Closing of Common Stock Offering
GlobeNewswire - Mon Oct 27, 3:01PM CDT
Nanosphere, Inc. (the "Company" (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced the closing of its previously announced underwritten public offering of 40,000,000 shares of its common stock at a public offering price of $0.50 per share. As part of the fee payable to the underwriters in connection with the offering, the Company also issued 400,000 shares of common stock to the underwriters. Chardan Capital Markets, LLC acted as the sole book-running manager for the offering.
NSPH: 0.37 (+0.02)

Ebola Hits NYC: Time To Panic
Matthew Finston - at Seeking Alpha - Mon Oct 27, 7:45AM CDT

BCRX: 10.23 (+0.14), TKMR: 13.12 (-0.19), NNVC: 2.61 (+0.03), INO: 8.34 (+0.08), CMRX: 34.77 (-0.27), APT: 2.52 (-0.07), HEB: 0.23 (-0.01), SRPT: 12.60 (-0.40), NLNK: 33.10 (-0.36), PLX: 2.02 (-0.12), SMED: 4.33 (+0.08), LAKE: 9.19 (-0.46), NSPH: 0.37 (+0.02), OSUR: 9.10 (unch)

Mali confirms first Ebola case
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 3:48AM CDT

BCRX: 10.23 (+0.14), GOLD: 61.78 (+0.58), AU: 7.52 (+0.04), VSR: 3.00 (-0.04), TKMR: 13.12 (-0.19), NNVC: 2.61 (+0.03), INO: 8.34 (+0.08), CMRX: 34.77 (-0.27), APT: 2.52 (-0.07), HEB: 0.23 (-0.01), SRPT: 12.60 (-0.40), SMED: 4.33 (+0.08), NLNK: 33.10 (-0.36), PLX: 2.02 (-0.12), LAKE: 9.19 (-0.46), NSPH: 0.37 (+0.02)

NYC doctor tests positive for Ebola; futures slip
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 8:57PM CDT

BCRX: 10.23 (+0.14), VSR: 3.00 (-0.04), TKMR: 13.12 (-0.19), NNVC: 2.61 (+0.03), INO: 8.34 (+0.08), SPY: 197.91 (-1.60), CMRX: 34.77 (-0.27), APT: 2.52 (-0.07), HEB: 0.23 (-0.01), SRPT: 12.60 (-0.40), SMED: 4.33 (+0.08), NLNK: 33.10 (-0.36), PLX: 2.02 (-0.12), LAKE: 9.19 (-0.46), NSPH: 0.37 (+0.02)

Ebola-stoked stocks rise
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 2:49PM CDT

BCRX: 10.23 (+0.14), VSR: 3.00 (-0.04), TKMR: 13.12 (-0.19), NNVC: 2.61 (+0.03), INO: 8.34 (+0.08), CMRX: 34.77 (-0.27), APT: 2.52 (-0.07), HEB: 0.23 (-0.01), SRPT: 12.60 (-0.40), SMED: 4.33 (+0.08), NLNK: 33.10 (-0.36), PLX: 2.02 (-0.12), LAKE: 9.19 (-0.46), NSPH: 0.37 (+0.02)

Stock to Watch: Nanosphere Down 36.7% (NSPH)
Comtex SmarTrend(R) - Wed Oct 22, 10:16AM CDT
Nanosphere (NASDAQ:NSPH) is one of today's worst performing penny stocks, down 36.7% to $0.47 on 3.7x average daily volume. Thus far today, Nanosphere has traded 5.6 million shares, vs. average volume of 1.5 million shares per day. The stock has underperformed the Dow (-37.0% to the Dow's 0.0%) and underperformed the S&P 500 (-37.0% to the S&P's 0.2%) during today's trading.
NSPH: 0.37 (+0.02)

Nanosphere prices stock offering
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 9:04AM CDT

NSPH: 0.37 (+0.02)

Nanosphere Prices $20 Million Public Offering of Common Stock
GlobeNewswire - Wed Oct 22, 8:44AM CDT
Nanosphere, Inc. (the "Company" (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced the pricing of its previously announced underwritten public offering of 40,000,000 shares of its common stock at a public offering price of $0.50 per share. In connection with the offering, the Company has also granted the underwriters a 30-day option to purchase up to an additional 6,000,000 shares of common stock to cover over-allotments, if any. As part of the fee payable to the underwriters in connection with the offering, the Company will issue 400,000 shares of common stock to the underwriters, plus up to an additional 60,000 shares of common stock in the event that the underwriters exercise their over-allotment option. Chardan Capital Markets, LLC is acting as the sole book-running manager for the offering.
NSPH: 0.37 (+0.02)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 112

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 94

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 160

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 135

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 157

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 142

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 118

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 111

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 97

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 94

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading

Top 5 Most Recently Viewed Articles

Health-Ade Partners with Wheel of Fortune and Ryan Seacrest

Updated Category News Views 212

Health-Ade Shines at Wheel of Fortune Premiere Health-Ade is thrilled to announce its prominent involvement in the premiere week of the classic game show, Wheel of Fortune, as it embarks on an exciting new journey with Ryan Seacrest as the show's host. This is an exhilarating moment not only for Wheel of Fortune but also for Health-Ade Kombucha, which is celebrated for...

Continue Reading
Investment Fund Trends and Insights for October 2024

Updated Category News Views 101

Mutual Fund and ETF Asset Management In the scope of mutual funds and exchange-traded funds (ETFs), the latest insights reveal a steady growth in assets and sales throughout the investment landscape. As investors look for diverse options, investment funds have shown resilience and dynamic adaptability, showcasing robust growth metrics in their respective categories....

Continue Reading
S&P and Pantera Take Digital Asset Indexing to New Heights

Updated Category News Views 18

Digital Assets: A New Benchmark in Town Date it, folks: July 21, 2026. S&P Dow Jones Indices and Pantera Capital are rolling out a fresh digital asset index. They're slapping the 'S&P Pantera' name on something focused less on the casino vibe you get from memes and Bitcoin mania, and more on actual economic value and real-world use. Flipping the script on the way most of...

Continue Reading
Gundry MD Wins Big with Innovative Softgel Formula

Updated Category News Views 57

Breaking New Ground in Weight Management Forget the caffeine-laden pills and appetite-killer potions—here comes something that simply whispers to your gut and says, "Manage your weight naturally." That's what Gundry MD's Daily Weight Advantage™ has cooked up, bagging the prestigious NutraIngredients-USA's Weight Management Product of 2026 award. Finally, a product...

Continue Reading
Ciena's Options Market Insights: Bullish Trends and Growth Prospects

Updated Category News Views 202

Understanding Ciena's Recent Options Activity Investors with significant resources have shown a clear bullish sentiment towards Ciena (NYSE: CIEN), indicating crucial trends that market observers should consider. By monitoring options records, it’s clear that substantial movements are occurring within the CIEN stock, hinting that noteworthy developments might be on the...

Continue Reading